BLLN
BillionToOne, Inc. Class A Common Stock
NASDAQ: BLLN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$132.52
-0.84% today
Updated 2026-07-29
Market cap
$5.93B
P/E ratio
238.78
P/S ratio
16.73x
EPS (TTM)
$0.54
Dividend yield
—
52W range
$62 – $139
Volume
0.7M
WallStSmart proprietary scores
40
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A8.5
Quality
A5.5
Profitability
C+4.0
Valuation
C4/9
Piotroski F-Score
Moderate
2.8
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$122.14
-7.83%
12-Month target
$0.95
-99.28%
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy4 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $10.96M — positive
+ Revenue growth 83.80% QoQ
+ Debt/equity 0.29x — low leverage
Risks
- P/E 238.78x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
| Revenue | $71.73M | $152.58M | $305.11M | $354.54M |
| Net income | $-82.68M | $-41.57M | $7.45M | $17.97M |
| EPS | — | — | — | $0.54 |
| Free cash flow | $-59.85M | $-46.78M | $15.71M | $10.96M |
| Profit margin | -115.27% | -27.24% | 2.44% | 7.02% |
Peer comparison
Smart narrative
BillionToOne, Inc. Class A Common Stock trades at $132.52. representing a P/E of 238.78x trailing earnings. Our Smart Value Score of 40/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.78, it sits in the grey zone. TTM revenue stands at $354.54M. with profit margins at 7.02%.
Frequently asked questions
What is BillionToOne, Inc. Class A Common Stock's stock price?
BillionToOne, Inc. Class A Common Stock (BLLN) trades at $132.52, on a P/E of 238.8x and a P/S of 16.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is BillionToOne, Inc. Class A Common Stock overvalued?
BillionToOne, Inc. Class A Common Stock carries a Smart Value Score of 40/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of BillionToOne, Inc. Class A Common Stock (BLLN)?
The 12-month analyst consensus target is $122.14, about 7.8% below the current $132.52. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is BillionToOne, Inc. Class A Common Stock's revenue?
BillionToOne, Inc. Class A Common Stock's trailing twelve-month revenue is $354.54M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
BillionToOne, Inc. Class A Common Stock's Altman Z-Score is 2.78, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio16.73x
ROE4.99%
Beta—
50D MA$106.77
200D MA$93.33
Shares out0.04B
Float0.02B
Short ratio—
Avg volume0.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—